National Casein is a leading provider of specialty proteins. The Company offers several specialty packaging applications and adhesives for sheeting. National Casein also serves clients worldwide. The Company’s main business activity is in the manufacturing and marketing of dietary supplement proteins. These dietary supplements are primarily manufactured to promote physical fitness, weight loss and energy production.
The Company’s protein formula includes an improved an alternative release method for the manufacture of casein. This process results in improved quality with increased shelf life. The improved an alternative release method also results in a reduction in wastage, an increase in the manufacturing cost per product, and an increase in the company’s income from sales of these products. In addition, public or chemical is used in the processing and packaging processes of casein, to ensure superior quality.
The Company’s quality control program includes on-site consequence analysis, as well as risk management plan audits. The on-site consequence analysis involves tests conducted at the facilities where the proteins are produced. These tests identify any off-site consequence of using National Casein, such as allergic reactions, such as runny nose, and skin rash. The tests also identify the conditions in which the proteins can be stored safely and for prolonged periods of time, such as high temperature storage. The risk management plan audits also identify any conditions that are not adequately covered by the product or under regulated by the FDA, such as cardiovascular side effects and neuropsychological side effects.
There is a risk management plan in place for the use of the National Casein brand. In the event that an allergic reaction develops as a result of the use of casein, the Company has established an early-aid protocol, which is followed, to provide immediate medical attention and to avert complications, which would occur in the event that the proteins were not administered in the exact quantities necessary. In the event that an adverse reaction occurred, it is critical that all employees are provided with an explanation, so they are able to report the occurrence of the allergic reaction and ask for medical assistance. The use of National Casein as a supplement enhances wound healing, reduces pain, and improves functioning of the lymphatic and blood systems.
The company has conducted clinical trials for both its products and its adherence to the latest guidelines and standards of care. One of the major components that the Company has determined to be effective in its pursuit of protecting the health of those that use the product is its adherence to the latest rap submission guidelines. This evidence was documented in a study entitled “Casein in Caseco: An Rmp Adhesives Processes Study” published in the Journal of Pharmaceuticals in May 2021. This study utilized data from over 400 case reports that had been submitted to the FDA by the suppliers. Based upon this information, the Casein in Caseco manufacturers formulated their own voluntary quality parameters for the testing of Casein in caseco adhesives.
Based on the results of the Casein in Caseco review date, the safety of the supplementation has been established and is considered to be of high quality. Therefore, it is important for the supplement manufacturers to regularly conduct quality assurance tests, as required by the Food and Drug Administration (FDA). Manufacturers should also conduct random audits on their manufacturing facilities and manufacturing plants to identify any issues that may pose a threat to the general public’s health. Such audits and risk management plans can be implemented by the companies at the manufacturing, processing, packaging, and storage facility, and through the distribution channels.
